[email protected]
CAS 1093403-33-8 SRT2104 (GSK2245840) molecular structure lightbox
CAS RN: 1093403-33-8

SRT2104 (GSK2245840)

Product Availability

Choose a grade to view its available package options.

7 package records6 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250505 100mg In stock Shanghai Inquiry
Batchno.20260628 10mg In stock Shanghai Inquiry
Batchno.20251025 1g Out of stock Inquiry
Batchno.20251017 1mg In stock Shanghai Inquiry
Batchno.20250208 250mg In stock Shanghai Inquiry
Batchno.20250413 50mg In stock Shanghai Inquiry
Batchno.20250209 5mg In stock Shanghai Inquiry
  • Product code: SSC-010604
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 0.25g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 1093403-33-8
Pack Size Recorded Purity Available Qty Ship From Inquiry
0.25g ≥95% 0 Out of Stock Hong Kong Inquiry

1093403-33-8 / 4-methyl-N-[2-[3-(morpholin-4-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-pyridin-3-yl-1,3-thiazole-5-carboxamide

SRT2104 | SRT-2104 | 4521NR0J09

Standard CAS: 1093403-33-8 Multi CAS: No
Basic Information Computed Properties

Basic Information

CAS
1093403-33-8
Multi CAS
No
Molecular Formula
C26H24N6O2S2
Molecular Weight
516.600000
Exact Mass
516.140216
SMILES
CC1=C(SC(=N1)C2=CN=CC=C2)C(=O)NC3=CC=CC=C3C4=CN5C(=CSC5=N4)CN6CCOCC6
InChI
InChI=1S/C26H24N6O2S2/c1-17-23(36-25(28-17)18-5-4-8-27-13-18)24(33)29-21-7-3-2-6-20(21)22-15-32-19(16-35-26(32)30-22)14-31-9-11-34-12-10-31/h2-8,13,15-16H,9-12,14H2,1H3,(H,29,33)
InChIKey
LAMQVIQMVKWXOC-UHFFFAOYSA-N
Synonyms
SRT2104 SRT-2104 4521NR0J09 4-methyl-N-[2-[3-(morpholin-4-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-pyridin-3-yl-1,3-thiazole-5-carboxamide 4-methyl-N-(2-(3-(morpholin-4-ylmethyl)imidazo(2,1-b)(1,3)thiazol-6-yl)phenyl)-2-pyridin-3-yl-1,3-thiazole-5-carboxamide

Computed Properties

Structural Parameters

Heavy atom count
36
Aromatic heavy atom count
25
Fraction Csp3
0.23
Rotatable bonds
6
H-bond acceptors
9
H-bond donors
1
Molar refractivity
142.64
TPSA
84.65

LogP / Solubility

WLOGP
4.97
MLOGP
4.42
XLogP3
4.2
Consensus LogP
4.53
Log S (ESOL)
-6.29
Class (ESOL)
Insoluble
Log S (Ali)
-7.39
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.87
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.34

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
5.5

Customers Also Viewed

Get In Touch

Contact Us